Clinical Trial Update: Alleviation of Cedar Pollen Induced Allergic Symptoms by Orally Taken Superfine Beta-1,3-Glucan [Phase 4]

View source ↗

Summary

A Phase 4 trial evaluated whether orally administered superfine beta-1,3-Glucan reduces cedar pollen–induced allergic symptoms, including allergic conjunctiviti…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Allergic Conjunctivitis

Drugs mentioned

• Superfine Beta-1,3-Glucan (beta-1,3-glucan)

Snippet

Sponsor: Meiji University of Oriental Medicine | Conditions: Allergic Conjunctivitis | Phase 4 | Status: TERMINATED